期刊
MICROBES AND INFECTION
卷 23, 期 4-5, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.micinf.2021.104795
关键词
Acinetobacter baumannii; Persister; Combination therapy; Colistin; Tobramycin
资金
- Indian Council of Medical Research, New Delhi, India [OMI/17/2014-ECD-1]
The combination of tobramycin and colistin has shown promising results in eradicating persister cells of Acinetobacter baumannii, suggesting a potential strategy for preventing relapse of infections caused by this pathogen.
Acinetobacter baumannii, a leading cause of nosocomial infections, is a serious health threat. Limited therapeutic options due to multi-drug resistance and tolerance due to persister cells have urged the scientific community to develop new strategies to combat infections caused by this pathogen effectively. Since combination antibiotic therapy is an attractive strategy, the effect of combinations of antibiotics, belonging to four classes, was investigated on eradication of persister cells in A. baumannii. Among the antibiotics included in the study, tobramycin-based combinations were found to be the most effective. Tobramycin, in combination with colistin or ciprofloxacin, eradicated persister cells in A. baumannii in late exponential and stationary phases of growth. Mechanistically, colistin facilitated the entry of tobramycin into cells by increasing membrane permeability and inducing hyperpolarization of the inner membrane accompanied by increase in ROS production. Expression of the genes encoding universal stress protein and efflux pumps was down-regulated in response to tobramycin and colistin, suggesting increased lethality of their combination that might be responsible for eradication of persister cells. Thus, a combination of tobramycin and colistin could be explored as a promising option for preventing the relapse of A. baumannii infections due to persister cells. (c) 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据